Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
45.68
+0.58 (1.29%)
Dec 5, 2025, 4:00 PM EST - Market closed
Supernus Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,619 | 1,997 | 1,581 | 1,928 | 1,551 | 1,326 | |
| Market Cap Growth | 33.51% | 26.29% | -18.00% | 24.34% | 16.99% | 6.52% | |
| Enterprise Value | 2,380 | 1,632 | 1,398 | 1,849 | 1,128 | 1,019 | |
| Last Close Price | 45.68 | 36.16 | 28.94 | 35.67 | 29.16 | 25.16 | |
| PE Ratio | - | 27.03 | 1201.42 | 31.76 | 29.03 | 10.44 | |
| Forward PE | 17.76 | 19.65 | 15.34 | 30.84 | 15.73 | 15.73 | |
| PS Ratio | 3.75 | 3.02 | 2.60 | 2.89 | 2.68 | 2.55 | |
| PB Ratio | 2.49 | 1.93 | 1.72 | 2.18 | 1.90 | 1.78 | |
| P/TBV Ratio | 8.53 | 5.03 | 7.73 | 28.90 | - | 4.38 | |
| P/FCF Ratio | 37.02 | 11.66 | 14.30 | 16.56 | 12.40 | 9.84 | |
| P/OCF Ratio | 36.44 | 11.61 | 14.23 | 16.51 | 12.20 | 9.58 | |
| PEG Ratio | 0.47 | 1.11 | 1.11 | 1.11 | 1.11 | 1.11 | |
| EV/Sales Ratio | 3.49 | 2.47 | 2.30 | 2.77 | 1.95 | 1.96 | |
| EV/EBITDA Ratio | 20.01 | 11.51 | 14.23 | 14.10 | 10.06 | 5.26 | |
| EV/EBIT Ratio | 70.95 | 26.59 | 104.31 | 40.53 | 14.18 | 5.80 | |
| EV/FCF Ratio | 33.64 | 9.53 | 12.65 | 15.88 | 9.01 | 7.56 | |
| Debt / Equity Ratio | 0.04 | 0.03 | 0.05 | 0.51 | 0.54 | 0.59 | |
| Debt / EBITDA Ratio | 0.32 | 0.22 | 0.37 | 3.13 | 3.55 | 2.17 | |
| Debt / FCF Ratio | 0.60 | 0.20 | 0.38 | 3.87 | 3.52 | 3.24 | |
| Asset Turnover | 0.49 | 0.50 | 0.41 | 0.39 | 0.36 | 0.39 | |
| Inventory Turnover | 1.06 | 1.18 | 0.99 | 0.98 | 1.12 | 1.40 | |
| Quick Ratio | 1.37 | 2.04 | 1.38 | 0.91 | 1.55 | 2.30 | |
| Current Ratio | 1.80 | 2.35 | 1.70 | 1.07 | 1.91 | 2.57 | |
| Return on Equity (ROE) | -1.86% | 7.55% | 0.15% | 7.13% | 6.85% | 18.94% | |
| Return on Assets (ROA) | 1.52% | 2.90% | 0.56% | 1.68% | 3.11% | 8.24% | |
| Return on Capital (ROIC) | 1.96% | 3.77% | 0.73% | 2.20% | 4.08% | 10.08% | |
| Return on Capital Employed (ROCE) | 3.10% | 5.70% | 1.40% | 4.50% | 5.80% | 13.90% | |
| Earnings Yield | -0.73% | 3.70% | 0.08% | 3.15% | 3.45% | 9.58% | |
| FCF Yield | 2.70% | 8.58% | 6.99% | 6.04% | 8.07% | 10.16% | |
| Buyback Yield / Dilution | -0.54% | -0.81% | 10.01% | -13.47% | -1.24% | 0.24% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.